×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
18:00
Introduction
Dr Leïla Bengrine-Lefevre
18:05
Les nouvelles recommandations St-Paul-de-Vence appliquées en vraie vie:
  • Cas clinique d’une patiente en première ligne d’un cancer de l’ovaire avancé
    Dr Fernando Bazan
     
  • Cas Clinique d’une patiente en rechute d’un cancer de l’ovaire avancé
    Dr Leïla Bengrine-Lefevre
19:05
Défauts de la recombinaison homologue (HRD):  définition et perspectives thérapeutiques
Dr Elisabeth Luporsi
19:25
La chirurgie à l’ère des PARP Inhibiteurs
Pr Chérif Akladios
19:55 Conclusion

 

Shooting date : 2021-07-12
Last update : 2021-12-23
1 comment
Join the Discussion
  • mohamed S. merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, June 18th 2024 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, June 18th 2024 from 07am to 08:30am (GMT+2)
    San Francisco : Tuesday, June 18th 2024 from 10am to 11:30am (GMT+2)
    New York : Tuesday, June 18th 2024 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Tuesday, June 18th 2024 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Tuesday, June 18th 2024 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Tuesday, June 18th 2024 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Tuesday, June 18th 2024 from 07pm to 08:30pm (GMT+2)
    Istanbul : Tuesday, June 18th 2024 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, June 18th 2024 from 09pm to 10:30pm (GMT+2)
    Bangkok : Wednesday, June 19th 2024 from 12am to 01:30am (GMT+2)
    Shanghai : Wednesday, June 19th 2024 from 01am to 02:30am (GMT+2)
    Tokyo : Wednesday, June 19th 2024 from 02am to 03:30am (GMT+2)
    Sydney : Wednesday, June 19th 2024 from 04am to 05:30am (GMT+2)
    Wellington : Wednesday, June 19th 2024 from 06am to 07:30am (GMT+2)

    La qualité de vie

    et le cancer de l'ovaire

    Share
    Wednesday, November 10th 2021 from 06pm to 07:30pm (GMT+1)
    Honolulu : Wednesday, November 10th 2021 from 07am to 08:30am (GMT+1)
    San Francisco : Wednesday, November 10th 2021 from 09am to 10:30am (GMT+1)
    New York : Wednesday, November 10th 2021 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Wednesday, November 10th 2021 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Wednesday, November 10th 2021 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Wednesday, November 10th 2021 from 06pm to 07:30pm (GMT+1)
    Istanbul : Wednesday, November 10th 2021 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Wednesday, November 10th 2021 from 09pm to 10:30pm (GMT+1)
    Bangkok : Thursday, November 11th 2021 from 12am to 01:30am (GMT+1)
    Shanghai : Thursday, November 11th 2021 from 01am to 02:30am (GMT+1)
    Tokyo : Thursday, November 11th 2021 from 02am to 03:30am (GMT+1)
    Sydney : Thursday, November 11th 2021 from 03am to 04:30am (GMT+1)
    Wellington : Thursday, November 11th 2021 from 05am to 06:30am (GMT+1)

    La prise en compte de la qualité de vie, des choix des patientes en cancérologie gynécologique

    Comment passer des recommandations de Saint-Paul-de-Vence à la pratique quotidienne ?

    Share
    Monday, October 16th 2023 from 06pm to 07:30pm (GMT+2)
    Honolulu : Monday, October 16th 2023 from 07am to 08:30am (GMT+2)
    San Francisco : Monday, October 16th 2023 from 10am to 11:30am (GMT+2)
    New York : Monday, October 16th 2023 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Monday, October 16th 2023 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Monday, October 16th 2023 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Monday, October 16th 2023 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Monday, October 16th 2023 from 07pm to 08:30pm (GMT+2)
    Istanbul : Monday, October 16th 2023 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Monday, October 16th 2023 from 09pm to 10:30pm (GMT+2)
    Bangkok : Tuesday, October 17th 2023 from 12am to 01:30am (GMT+2)
    Shanghai : Tuesday, October 17th 2023 from 01am to 02:30am (GMT+2)
    Tokyo : Tuesday, October 17th 2023 from 02am to 03:30am (GMT+2)
    Sydney : Tuesday, October 17th 2023 from 04am to 05:30am (GMT+2)
    Wellington : Tuesday, October 17th 2023 from 06am to 07:30am (GMT+2)

    La nouvelle classification des cancers de l’endomètre en pratique

    Cycle d'enseignement - Les cancers gynécologiques

    Share
    Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
    Honolulu : Wednesday, March 20th 2024 from 08am to 09am (GMT+1)
    San Francisco : Wednesday, March 20th 2024 from 10am to 11am (GMT+1)
    New York : Wednesday, March 20th 2024 from 01pm to 02pm (GMT+1)
    Buenos Aires : Wednesday, March 20th 2024 from 03pm to 04pm (GMT+1)
    London / Dublin : Wednesday, March 20th 2024 from 06pm to 07pm (GMT+1)
    Paris / Berlin : Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
    Istanbul : Wednesday, March 20th 2024 from 08pm to 09pm (GMT+1)
    Moscou / Dubaï : Wednesday, March 20th 2024 from 10pm to 11pm (GMT+1)
    Bangkok : Thursday, March 21st 2024 from 01am to 02am (GMT+1)
    Shanghai : Thursday, March 21st 2024 from 02am to 03am (GMT+1)
    Tokyo : Thursday, March 21st 2024 from 03am to 04am (GMT+1)
    Sydney : Thursday, March 21st 2024 from 04am to 05am (GMT+1)
    Wellington : Thursday, March 21st 2024 from 06am to 07am (GMT+1)

    Immunothérapies et inhibiteurs de PARP dans la prise en charge du cancer de l’endomètre avancé ...

    éclairages du congrès de la SGO

    Share
    Scroll Up